Roles of the monoaminergic system in the antidepressant effects of ketamine and its metabolites
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Roles of the monoaminergic system in the antidepressant effects of ketamine and its metabolites
Authors
Keywords
-
Journal
NEUROPHARMACOLOGY
Volume -, Issue -, Pages 109313
Publisher
Elsevier BV
Online
2022-11-01
DOI
10.1016/j.neuropharm.2022.109313
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search
- (2022) Jordi Bonaventura et al. MOLECULAR PSYCHIATRY
- Attenuated dopamine signaling after aversive learning is restored by ketamine to rescue escape actions
- (2021) Mingzheng Wu et al. eLife
- Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine
- (2020) Briana K. Chen et al. NEUROPSYCHOPHARMACOLOGY
- Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function
- (2019) Eric W. Lumsden et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function
- (2019) Ronald S. Duman et al. MOLECULAR PSYCHIATRY
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine
- (2019) Xavier López-Gil et al. ACS Chemical Neuroscience
- Stress-sensitive antidepressant-like effects of ketamine in the mouse forced swim test
- (2019) Paul J. Fitzgerald et al. PLoS One
- Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression
- (2019) Ella J. Daly et al. JAMA Psychiatry
- (R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism
- (2019) Yukio Ago et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Esketamine is approved in Europe for treating resistant major depressive disorder
- (2019) Elisabeth Mahase BMJ-British Medical Journal
- Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
- (2018) Carla M. Canuso et al. AMERICAN JOURNAL OF PSYCHIATRY
- Common Neurotransmission Recruited in ( R , S )-Ketamine and (2 R ,6 R )-Hydroxynorketamine–Induced Sustained Antidepressant-like Effects
- (2018) Thu Ha Pham et al. BIOLOGICAL PSYCHIATRY
- AMPA Receptor Activation–Independent Antidepressant Actions of Ketamine Metabolite ( S )-Norketamine
- (2018) Chun Yang et al. BIOLOGICAL PSYCHIATRY
- Ketamine-Induced Prefrontal Serotonin Release Is Mediated by Cholinergic Neurons in the Pedunculopontine Tegmental Nucleus
- (2018) Haruko Kinoshita et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Mechanisms of ketamine action as an antidepressant
- (2018) P Zanos et al. MOLECULAR PSYCHIATRY
- (2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice
- (2018) Jun-ichi Yamaguchi et al. NEUROPSYCHOPHARMACOLOGY
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy
- (2018) Allie J. Widman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
- (2018) Ella J. Daly et al. JAMA Psychiatry
- Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine
- (2018) Kenichi Fukumoto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 5-Hydroxytryptamine-Independent Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model
- (2017) Kai Zhang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Role of 5-HT1A Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine
- (2017) Kenichi Fukumoto et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography
- (2017) Marie Spies et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine
- (2017) Yukihiko Shirayama et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive N -Methyl-d-Aspartate Receptor Antagonist in Rodents: Evidence Supporting the Use of mGlu2/3 Antagonists, for the Treatment of Depression.
- (2017) J.M. Witkin et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders
- (2017) M Kokkinou et al. MOLECULAR PSYCHIATRY
- Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice
- (2017) T.H. Pham et al. NEUROPHARMACOLOGY
- Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
- (2017) Tung-Ping Su et al. NEUROPSYCHOPHARMACOLOGY
- Glial GLT-1 blockade in infralimbic cortex as a new strategy to evoke rapid antidepressant-like effects in rats
- (2017) J Gasull-Camós et al. Translational Psychiatry
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Ketamine Mechanism of Action: Separating the Wheat from the Chaff
- (2016) Todd D Gould et al. NEUROPSYCHOPHARMACOLOGY
- Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression
- (2016) Kristian Gaarn du Jardin et al. PSYCHOPHARMACOLOGY
- Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
- (2015) D. Jeffrey Newport et al. AMERICAN JOURNAL OF PSYCHIATRY
- Dopamine D2/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test
- (2015) Yan Li et al. BEHAVIOURAL BRAIN RESEARCH
- Circuit Architecture of VTA Dopamine Neurons Revealed by Systematic Input-Output Mapping
- (2015) Kevin T. Beier et al. CELL
- Activation of AMPA Receptors Mediates the Antidepressant Action of Deep Brain Stimulation of the Infralimbic Prefrontal Cortex
- (2015) Laura Jiménez-Sánchez et al. CEREBRAL CORTEX
- The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN
- (2015) Kenichi Fukumoto et al. NEUROPSYCHOPHARMACOLOGY
- Optogenetic stimulation of infralimbic PFC reproduces ketamine’s rapid and sustained antidepressant actions
- (2015) Manabu Fuchikami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
- (2015) C Yang et al. Translational Psychiatry
- Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats
- (2014) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- Restoring Mood Balance in Depression: Ketamine Reverses Deficit in Dopamine-Dependent Synaptic Plasticity
- (2014) Pauline Belujon et al. BIOLOGICAL PSYCHIATRY
- Raphe AMPA receptors and nicotinic acetylcholine receptors mediate ketamine-induced serotonin release in the rat prefrontal cortex
- (2014) Naoya Nishitani et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Involvement of prefrontal AMPA receptors in encounter stimulation-induced hyperactivity in isolation-reared mice
- (2014) Ryota Araki et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Effects ofN-Acetylaspartylglutamate (NAAG) Peptidase Inhibition on Release of Glutamate and Dopamine in Prefrontal Cortex and Nucleus Accumbens in Phencyclidine Model of Schizophrenia
- (2012) Daiying Zuo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Presynaptic 4 2 Nicotinic Acetylcholine Receptors Increase Glutamate Release and Serotonin Neuron Excitability in the Dorsal Raphe Nucleus
- (2012) J. Garduno et al. JOURNAL OF NEUROSCIENCE
- Interneuron dysfunction in psychiatric disorders
- (2012) Oscar Marín NATURE REVIEWS NEUROSCIENCE
- Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression
- (2011) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- Importance of inter-hemispheric prefrontal connection in the effects of non-competitive NMDA receptor antagonists
- (2011) Xavier López-Gil et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The NADPH Oxidase NOX2 Controls Glutamate Release: A Novel Mechanism Involved in Psychosis-Like Ketamine Responses
- (2010) S. Sorce et al. JOURNAL OF NEUROSCIENCE
- Effects of lamotrigine on PCP-evoked elevations in monoamine levels in the medial prefrontal cortex of freely moving rats
- (2010) Davide Quarta et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Mechanisms underlying ketamine-induced synaptic depression in rat hippocampus-medial prefrontal cortex pathway
- (2010) H. Kamiyama et al. NEUROSCIENCE
- Glutamate Receptor Ion Channels: Structure, Regulation, and Function
- (2010) S. F. Traynelis et al. PHARMACOLOGICAL REVIEWS
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
- (2009) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex
- (2009) Zhimin Li et al. BRAIN RESEARCH
- Combined administration of an mGlu2/3 receptor agonist and a 5-HT2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants
- (2009) Jason M. Uslaner et al. PSYCHOPHARMACOLOGY
- Interaction between orexinergic neurons and NMDA receptors in the control of locus coeruleus–cerebrocortical noradrenergic activity of the rat
- (2008) Ryuji Tose et al. BRAIN RESEARCH
- The absence of 5-HT1A receptors has minor effects on dopamine but not serotonin release evoked by MK-801 in mice prefrontal cortex
- (2008) Anna Castañé et al. PSYCHOPHARMACOLOGY
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search